Investors
Quick Explorer
About Paras Health
We are a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services through a network of eight hospitals with an aggregate bed capacity of 2,211 beds as of March 31, 2026 across North India, Bihar and Jharkhand. We operate under the "Paras Health" brand, with a presence in five states and one union territory - Gurugram and Panchkula in Haryana; Patna and Darbhanga in Bihar; Kanpur in Uttar Pradesh; Udaipur in Rajasthan; Ranchi in Jharkhand; and Srinagar in the union territory of Jammu and Kashmir. We offer several clinical specialties across our hospitals including cardiac sciences, oncology, neuro sciences, gastro sciences and orthopedics and joint replacement. Our hospitals are designed to deliver high-acuity care and offer treatments across a broad spectrum of clinical specialties, with a deep focus on cardiac sciences, oncology sciences, neuro sciences, gastro sciences, orthopedics and sports injury, and renal sciences (collectively, “CONGOR”). Our extensive 20 years of experience in the healthcare industry in North India has helped us develop a strong understanding of the region’s market dynamics. This, along with our flexible operating model have enabled us to build an asset light business with strong unit economics.
We established our first hospital in Gurugram, Haryana in 2006 with 200 beds, making us the first corporate hospital entrant among our peers in the city. (Source: CRISIL Report). We have increased our total bed capacity from 2,135 beds as of March 31, 2024 to 2,211 beds as of March 31, 2026, and are one of the largest healthcare providers in North India, Bihar and Jharkhand in terms of bed capacity as of March 31, 2026. (Source: CRISIL Report). In Gurugram, we are increasing our footprint and setting up another hospital with a bed capacity of 300 beds, which we intend to launch by Fiscal 2027, through a long-term lease arrangement. In April 2024, we entered into a lease deed to operate and manage the Gurugram II Hospital for a term of 29 years and 11 months with the option to renew the lease for a further period of 15 years on mutually agreed terms. We have issued a security deposit of ₹ 30.00 million in favour of the lessor. We are also setting up our first hospital in Ludhiana through a long-term lease arrangement and intend to launch it in Fiscal 2028 with a bed capacity of up to 500 beds.
Board Of Directors
Dr. Dharminder Kumar Nagar
Managing Director
Dr. Kapil Garg
Whole Time Director
Mr. Kabir Kishin Thakur
Non-Executive Director (nominee of Commelina Ltd)
Mr. Saurabh Sood
Chairman and Non-Executive Director
Mr. Nakul Anand
Independent Director
Mrs. Usha Rajeev
Independent Director
Mr. Upendra Prasad Singh
Independent Director
Key Management Personnel
Dr. Dharminder Kumar Nagar
Managing Director
Dr. Kapil Garg
Whole Time Director
Mr. Dilip Bidani
Group Chief Financial Officer
Mr. Rahul Kumar
Company Secretary, Compliance Officer and General Manager – Legal & Secretarial
Senior Management Personnel
Mr. Dilip Bidani
Group Chief Financial Officer
Mr. Rahul Kumar
Company Secretary, Compliance Officer and General Manager – Legal & Secretarial
Mr. Vineet Aggarwal
Group Chief Operating Officer
Balkishan Sharma
Chief Human Resources & Business Transformation Officer
Dr. Sonia Verma
Group Head – Projects CBU & Services
Disclaimer – Important
PLEASE READ THIS DISCLAIMER CAREFULLY. IT APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the draft red herring prospectus (“Draft Red Herring Prospectus”) and the draft abridged prospectus (“Draft Abridged Prospectus”) of Paras Healthcare Limited (“Company”), each dated June 4, 2026, filed with the Securities and Exchange Board of India (“SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) and hosted on this website in connection with the initial public offering of the equity shares of face value ₹1 each of the Company (“Equity Shares”) (“Offer”). You are advised to read the following notice carefully before accessing the Draft Red Herring Prospectus and the Draft Abridged Prospectus. In accessing the Draft Red Herring Prospectus and the Draft Abridged Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.
Access to the Draft Red Herring Prospectus and the Draft Abridged Prospectus does not constitute a recommendation by the Company, the members of the Syndicate (as defined in the Draft Red Herring Prospectus) or any of their respective affiliates or any other person to subscribe to the Equity Shares offered in the Offer.
The Draft Red Herring Prospectus and the Draft Abridged Prospectus are directed at, and are intended for distribution to, and use by, residents of India only. Residents of countries other than India are not authorized to view or use the information in this portion of our website. The information in this portion of our website, including the Draft Red Herring Prospectus and the Draft Abridged Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. The contents of the Draft Red Herring Prospectus and the Draft Abridged Prospectus are for your information only, and you acknowledge that access to the Draft Red Herring Prospectus and the Draft Abridged Prospectus is intended for use by you only and you agree not to forward the Draft Red Herring Prospectus and the Draft Abridged Prospectus on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents of the Draft Red Herring Prospectus and the Draft Abridged Prospectus shall be copied or duplicated in any form by any means or redistributed.
The Draft Red Herring Prospectus and the Draft Abridged Prospectus has been hosted on this website as prescribed under Regulation 26(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, (the “SEBI ICDR Regulations”). Our Company has taken all necessary steps to ensure that the contents of the Draft Red Herring Prospectus and the Draft Abridged Prospectus as appearing on this website are identical to the Draft Red Herring Prospectus and the Draft Abridged Prospectus filed with the SEBI. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates, directors, agents, officers, representatives, advisers, or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.
The Draft Red Herring Prospectus and the Draft Abridged Prospectus do not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and are not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (“U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (a) in the United States only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to the private placement exemption set out in Section 4(a) of the U.S. Securities Act, and (b) outside the United States in “offshore transactions” as defined in and in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdictions where those offers and sales are made.
Any person into whose possession the Draft Red Herring Prospectus and the Draft Abridged Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Neither the Company nor any of its affiliates is soliciting any action based on the Draft Red Herring Prospectus and the Draft Abridged Prospectus, and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities. Potential investors should not rely on the Draft Red Herring Prospectus and the Draft Abridged Prospectus for any investment decision.
Any decision on whether to invest in the Equity Shares may only be made after a red herring prospectus has been filed with the Registrar of Companies, Haryana at Chandigarh and the SEBI and must be made solely on the basis of such red herring prospectus, as there may be material changes in the red herring prospectus compared to the Draft Red Herring Prospectus. Invitations to subscribe to or purchase the equity shares in the Offer will be made only pursuant to the red herring prospectus if the recipient is in India or the preliminary offering memorandum for the Offer, which comprises the red herring prospectus and the preliminary international wrap for the Offer, if the recipient is outside India. No person outside India is eligible to Bid for Equity Shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which shall contain the selling restrictions for the Offer outside India.
Any potential investor should note that investment in Equity Shares involves a high degree of risk and for details relating to such risk, please see the section titled “Risk Factors” of the red herring prospectus, when available.
Neither the Company nor any of its affiliates, directors, agents, officers, representatives, advisers, or employees will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Draft Red Herring Prospectus and the Draft Abridged Prospectus beyond the date of the Draft Red Herring Prospectus and the Draft Abridged Prospectus, respectively. The information contained in the Draft Red Herring Prospectus and the Draft Abridged Prospectus may not be updated since its original publication date and may not reflect the latest updates. The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.
Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions. Any other information contained in, or that can be accessed via our website does not constitute a part of the Draft Red Herring Prospectus and the Draft Abridged Prospectus.
IF YOU ARE NOT PERMITTED TO VIEW THE MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.
To access this information, you must confirm by pressing on the button marked “I Confirm” that, at the time of access you are located and resident in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.
The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.
